Muscle progenitor cell VEGF receptor signaling in patients with peripheral arterial disease - Clinical Trial
What is the Purpose of this Study?
Treatment
We are doing this study to learn more about the differences in the muscle and blood of people that have Peripheral Arterial Disease (PAD).
What is the Condition Being Studied?
Objective
Peripheral Arterial Disease.
Who Can Participate in the Study?
Key Eligibility
- Adults with Peripheral Arterial Disease (PAD) that are:
--- Scheduled to have open vascular reconstruction, OR
--- Scheduled to undergo limb amputation due to PAD, OR
--- People who are scheduled to undergo orthopedic surgery without a diagnosis of PAD
Age Group
Adults
What is Involved?
Description
If you choose to join this study you will:
- Have muscle and tissue collected at the time of surgery and/or
- Give a blood sample at the time of surgery
Study Details
Full Title
The Role of Muscle Progenitor Cell VEGF receptor signaling in the clinical manifestations of peripheral arterial disease
Principal Investigator
Vascular Surgeon
Protocol Number
IRB:
PRO00065709
Phase
Phase
N/A
Enrollment Status
Open for Enrollment